Horseback therapy may help Parkinson's patients move better
NCT ID NCT07802509
First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This pilot study tests whether hippotherapy, a type of physical therapy using the natural movement of a horse, can improve mobility, gait, balance, and quality of life in people with Parkinson's disease. Participants will be randomly assigned to receive either hippotherapy sessions or additional standard physiotherapy during a three-week rehabilitation program. The study measures changes in walking speed, balance, and self-perceived health to see if the horse's rhythmic motion offers unique benefits for movement.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Hippotherapy (horse-assisted physical therapy) compared with standard physiotherapy
- What this could lead to
- If hippotherapy improves mobility and balance in Parkinson's, it could become a complementary therapy to standard rehabilitation, enhancing daily function and quality of life.
- What could go wrong
- This is a small pilot study, so results may not be conclusive. Hippotherapy requires access to horses and may not be feasible for everyone, and individual responses can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Confirmed diagnosis of Parkinson's diagnosis * Age \> 18 Years; * Hoehn \& Yahr stage ≤ 4; * Category 3 in the Functional Ambulation Categories * Climbing stairs is possible (with support). Exclusion Criteria: * Severe cognitive impairment, defined by a score below 26 on the Montreal Cognitive Assessment (MoCa) * Body weight \> 90kg; * Horse hair allergy; * Other acute and subacute cardiovascular, respiratory, musculoskeletal or neurological disorders that constitute a contraindication to hippotherapy (i.e. a recent fracture); * Pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rehabilitation Centre Valens
RECRUITINGValens, Canton of St. Gallen, 7317, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Individualized 130 hz subthalamic temporal interference stimulation versus medication for motor symptoms in parkinson disease
- Parkinson's improvement activated by hula understanding (PAHU) - part 2
- Half a million people join quest to decode Parkinson's risk
- Can a diabetes drug slow Parkinson's? a trial puts it to the test
- A psychedelic compound may lift mood in Parkinson's, and a trial puts it to the test
- Mind-Controlled therapy: could brain signals help Parkinson's patients move better?